Effect of injection rate of contrast material on CT of hepatocellular carcinoma

AJR. American Journal of Roentgenology
Tomoaki IchikawaTsutomu Araki

Abstract

The purpose of this study was to assess the effect of two injection rates of contrast material (3 mL/sec and 5 mL/sec) in hepatic arterial dominant phase MDCT for the detection of small (< 2 cm) hepatocellular carcinomas. The injection rates 3 mL/sec and 5 mL/sec were used prospectively in imaging examinations of patients with the suspected diagnosis of hepatocellular carcinoma. Each group consisted of 30 patients by chance. The group that received injections at 3 mL/sec had 35 hepatocellular carcinoma lesions, and the 5 mL/sec group had 41 lesions. In all patients the dose and concentration of contrast material were 100 mL and 350 mg/mL iodine (total dose of iodine, 35 g). In each patient a mini-test-bolus technique was used with an additional 15 mL of contrast material to determine optimal scan delay after administration of contrast material. Receiver operating characteristic analysis was used to assess diagnostic performance with the two injection rates of contrast material. There were no statistically significant differences between the two groups in regard to area under the curve and sensitivity. These values for the 3 mL/sec group were 0.97 and 28/35 (80%) and for the 5 mL/sec group were 0.96 and 36/41 (88%). However, the...Continue Reading

References

Nov 1, 1995·Journal of Computer Assisted Tomography·T KimJ Okamura
Aug 7, 1998·AJR. American Journal of Roentgenology·T KimH Nakamura
Aug 23, 2000·AJR. American Journal of Roentgenology·W D FoleyA J Taylor

❮ Previous
Next ❯

Citations

Mar 22, 2008·AJR. American Journal of Roentgenology·Yumi YanagaYasuyuki Yamashita
Dec 6, 2006·European Journal of Radiology·Giuseppe BrancatelliValérie Vilgrain
Oct 31, 2006·Academic Radiology·Kevin S Berbaum
May 2, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Tatsuo KonoYasushi Kaji
Sep 9, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Xijiao LiuBin Song
Nov 17, 2007·Investigative Radiology·Dushyant V SahaniUNKNOWN Investigators of the IMPACT Study
Oct 7, 2021·The Cochrane Database of Systematic Reviews·Tin NadarevicDavor Štimac

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.